avutometinib,defactinib
verastem oncology
['defactinib', 'avutometinib']
avutometinib plus defactinib demonstrates promising activity in recurrent lgsoc #asco23 #asco2023 #ovca 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.